One patent currently held, every record listed here
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Oct 2037. from the record
Of the 4 now held by other companies, 3 name Fedson Inc. as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2037
Next term end
1
Patent families
When these terms end
Each bar runs from grant to computed term end. 2018 to 2040.
US 12,746,275
Implants for Release of Lipophilic or Amphiphilic Pharmaceutical Substances
Jul 17, 2040
20232028203320382040
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
1 pending application: term is not computable until grant.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends no later than Mar 2031 · Medium confidence
The most cited patent in this portfolio, cited by 16 later US patents, top 25% of utility patents granted in 2018 in our data. Protection runs to 2031. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by Fedson, Inc.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Implantable Devices for Drug Delivery with Reduced Burst Release | 1 in force | to Oct 2037 |
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,678,401 | Implantable Devices for Drug Delivery with Reduced Burst Release In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 4 patents in force now held by others · 3 patents ended · 1 application pending · 30 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed